Henan Lingrui Pharmaceutical Co., Ltd. (SHA:600285)
China · Delayed Price · Currency is CNY 21.88
+0.34 (1.58%)
Feb 3, 2026, 3:00 PM CST
SHA:600285 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 799.61 | 722.55 | 568.11 | 465.3 | 361.54 | 325.49 |
Depreciation & Amortization | 73.54 | 73.54 | 77.62 | 76.25 | 72.8 | 68.46 |
Other Amortization | 2.69 | 2.69 | 4.89 | 2.81 | 3.92 | 4.86 |
Loss (Gain) From Sale of Assets | -0.01 | -0.01 | -0.05 | -0.02 | -0.03 | -0.08 |
Asset Writedown & Restructuring Costs | 3.91 | 3.91 | 2.52 | 0.13 | 20.36 | 30.83 |
Loss (Gain) From Sale of Investments | -40.2 | -40.2 | -20.28 | -64.58 | -30.6 | -41.16 |
Provision & Write-off of Bad Debts | 5.23 | 5.23 | 4.64 | 1.99 | 2.07 | -0.48 |
Other Operating Activities | 64.97 | 1.69 | 3.83 | 5.82 | 12.17 | 1.73 |
Change in Accounts Receivable | 17.41 | 17.41 | -43.44 | -76.41 | 235.66 | -70.53 |
Change in Inventory | 31.88 | 31.88 | 26.9 | -58.19 | -105.69 | -44.51 |
Change in Accounts Payable | 52.43 | 52.43 | 197.7 | 477.76 | 261.4 | 194.99 |
Change in Other Net Operating Assets | 4.98 | 4.98 | 14.07 | 37.62 | 28.6 | - |
Operating Cash Flow | 1,016 | 875.86 | 813.43 | 834.91 | 845.69 | 450.53 |
Operating Cash Flow Growth | 55.20% | 7.68% | -2.57% | -1.27% | 87.71% | 0.08% |
Capital Expenditures | -119.72 | -115.11 | -21.2 | -26.99 | -76.91 | -71.82 |
Sale of Property, Plant & Equipment | 7.19 | 0.02 | 10.15 | 12.23 | 0.47 | 0.2 |
Cash Acquisitions | -672.55 | - | - | - | - | - |
Investment in Securities | -578.07 | -570.9 | -231.96 | -83.02 | -482.99 | 75.67 |
Other Investing Activities | 120.54 | 20.16 | 13.3 | 13.97 | 13.63 | 7.82 |
Investing Cash Flow | -1,243 | -665.83 | -229.7 | -83.81 | -545.79 | 11.87 |
Short-Term Debt Issued | - | 40.43 | 102.84 | 90 | 236.24 | 171.51 |
Total Debt Issued | 546.83 | 40.43 | 102.84 | 90 | 236.24 | 171.51 |
Short-Term Debt Repaid | - | -102.84 | -20 | -170 | -130 | -286.51 |
Long-Term Debt Repaid | - | -1.86 | -1.89 | -2.28 | -1.68 | - |
Total Debt Repaid | -154.7 | -104.7 | -21.89 | -172.28 | -131.68 | -286.51 |
Net Debt Issued (Repaid) | 392.13 | -64.27 | 80.96 | -82.28 | 104.56 | -115 |
Issuance of Common Stock | 35.14 | 35.14 | - | - | 75.91 | - |
Repurchase of Common Stock | -0.09 | -0.09 | -0.79 | -1.85 | -184.5 | - |
Common Dividends Paid | -513 | -451.34 | -344.28 | -288.84 | -223.83 | -179.12 |
Other Financing Activities | -0.55 | 8.62 | -8.62 | -0.12 | -3.09 | -12.09 |
Financing Cash Flow | -86.36 | -471.94 | -272.73 | -373.09 | -230.94 | -306.2 |
Foreign Exchange Rate Adjustments | -0.01 | 0.01 | -0 | 0.04 | -0.03 | -0.1 |
Net Cash Flow | -312.78 | -261.9 | 310.99 | 378.04 | 68.93 | 156.11 |
Free Cash Flow | 896.48 | 760.75 | 792.23 | 807.92 | 768.78 | 378.71 |
Free Cash Flow Growth | 46.74% | -3.97% | -1.94% | 5.09% | 103.00% | -3.17% |
Free Cash Flow Margin | 23.70% | 21.73% | 23.92% | 26.91% | 28.54% | 16.24% |
Free Cash Flow Per Share | 1.57 | 1.35 | 1.40 | 1.42 | 1.36 | 0.67 |
Cash Income Tax Paid | 505.76 | 493.41 | 476.55 | 395.21 | 356.59 | 314.51 |
Levered Free Cash Flow | 526.42 | 558.78 | 617.95 | 546.14 | 675.19 | 264.32 |
Unlevered Free Cash Flow | 528.31 | 558.94 | 618.08 | 546.85 | 676.38 | 265.01 |
Change in Working Capital | 106.47 | 106.47 | 172.14 | 347.22 | 403.46 | 60.88 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.